Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors

Journal of Clinical Psychiatry

Volumn 69, Issue 4, 2008, Pages 679-680

  Honda, Takashi ^a   Katano, Yoshiaki ^a   Toyoda, Hidenori ^a   Hayashi, Kazuhiko ^a   Ishigami, Masatoshi ^a   Nakano, Isao ^a   Goto, Hidemi ^a   Yamamoto, Koji ^a   Takamatsu, Junki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; BLOOD CLOTTING FACTOR 7; INTERFERON; PEGINTERFERON; RIBAVIRIN; SEROTONIN UPTAKE INHIBITOR;

ANEMIA; BLEEDING; COMBINATION CHEMOTHERAPY; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HEMOPHILIA; HEPATITIS C; HUMAN; LETTER; LIVER FAILURE; MONOTHERAPY; PRIORITY JOURNAL; RETINA HEMORRHAGE; RISK ASSESSMENT;

EID: 44849130866     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0423d     Document Type: Letter

References (10)

1. Martin KA, Krahn LE, Balan V, et al. Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding. J Clin Psychiatry 2007;68:1024-1026
2. Weinrieb RM, Auriacombe M, Lynch KG, et al. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry 2003;64:1502-1510
3. De Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319:1106-1109
4. Loftis JM, Hauser P. Safety of the treatment of interferon-alpha-induced depression. Psychosomatics 2003;44:524-526
5. Hejny C, Sternberg P, Lawson DH, et al. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 2001;131:782-787
6. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-966
7. Honda T, Toyoda H, Hayashi K, et al. Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C. JAMA 2005;293:1190-1192
8. Yamamoto K, Honda T, Matsushita T, et al. Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin. J Thromb Haemost 2006;4:469-470
9. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-1492
10. Morasco BJ, Rifai MA, Loftis JM, et al. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord 2007;103:83-90